Presentation TCT 2014 The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines? Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Sanjay Kaul September 13, 2014
Presentation TCT 2014 Dissecting the Evidence: Is There Anyone with Stroke Who Can Benefit from PFO Closure? Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, John D. Carroll September 13, 2014
Presentation TCT 2014 ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community? Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler September 13, 2014
Presentation TCT 2014 Meta-analyses of PFO Closure Trials for Stroke: What Is the Evidence? Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Abel Romero-Corral September 13, 2014
News Daily News El Cierre del FOP es Efectivo en la Mejora de los Síntomas de la Hipoxia Jason Kahn August 05, 2013
News Daily News AHA Statement Recommends Cardiac Cath Options for Pediatric Conditions Jason Kahn May 02, 2011